Elisa H. Ignatius
Infectious Disease | Hospital Medicine
5501 Hopkins Bayview Circle, Allergy & Asthma Center, 2nd Floor
Allergy & Asthma Center, 2nd Floor
Baltimore, MD 21224
Allergy & Asthma Center, 2nd Floor
Baltimore, MD 21224
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Structure of a Bronchiectasis and Nontuberculous Mycobacteria Care Center: A Position Statement by the Bronchiectasis & NTM Association.
Journal: Chest
Published: September 26, 2025
Phase 2C clinical trial of novel short-course regimens for the treatment of pulmonary tuberculosis: TBTC study 38/CRUSH-TB design.
Journal: Contemporary clinical trials
Published: June 05, 2025
ACTG A5409 (RAD-TB): Study Protocol for a Phase 2 Randomized, Adaptive, Dose-Ranging, Open-Label Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis.
Journal: Research square
Published: April 08, 2025
ACTG A5409 (RAD-TB): Study protocol for a phase 2 randomized, adaptive, dose-ranging, open-label trial of novel regimens for the treatment of pulmonary tuberculosis.
Journal: Trials
Published: January 30, 2025
Efficacies of omadacycline + amikacin + imipenem and an all-oral regimen omadacycline + clofazimine + linezolid in a mouse model of M. abscessus lung disease.
Journal: mSphere
Published: July 09, 2024
High-Dose Isoniazid Lacks EARLY Bactericidal Activity against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized Phase II Clinical Trial.
Journal: American journal of respiratory and critical care medicine
Published: April 02, 2024
Efficacies of three drug regimens containing omadacycline to treat Mycobacteroides abscessus disease.
Journal: Tuberculosis (Edinburgh, Scotland)
Published: November 10, 2023
Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-Containing Regimens for Drug-Sensitive Tuberculosis: 12-Week Results.
Journal: American journal of respiratory and critical care medicine
Published: December 01, 2022
Nebulized Bacteriophage in a Patient With Refractory Mycobacterium abscessus Lung Disease.
Journal: Open forum infectious diseases
Published: March 11, 2022
Pharmacokinetics of standard versus high-dose isoniazid for treatment of multidrug-resistant tuberculosis.
Journal: The Journal of antimicrobial chemotherapy
Published: November 27, 2021
A Semimechanistic Model of the Bactericidal Activity of High-Dose Isoniazid against Multidrug-Resistant Tuberculosis: Results from a Randomized Clinical Trial.
Journal: American journal of respiratory and critical care medicine
Published: August 17, 2021
Last Updated: 09/26/2026